MINAPHARM PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of MIPH for the last quarter is 1.08 B EGP, and it's 10.03% higher compared to the previous quarter. The net income of Q2 24 is -100.69 M EGP.